No Data
Why You Should Retain IQVIA Holdings Stock in Your Portfolio Now
How to adjust the new national medical insurance catalog? Here is the explanation.
1. The success rate is 76%, with an average decline of 63%. This year, the success rate and decline of negotiating/bidding pharmaceuticals are basically equivalent to previous years; 2. This year, the fund calculation will pay more attention to the impact on fund expenditure, while also enhancing the comprehensiveness and scientific nature of the calculation work; 3. This year's catalog adjustment places more emphasis on the actual clinical needs and patients' actual medication, highlighting support for true innovation.
The 40% Return Delivered to IQVIA Holdings' (NYSE:IQV) Shareholders Actually Lagged YoY Earnings Growth
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Goldman Sachs Adjusts Price Target on IQVIA Holdings to $230 From $250, Maintains Buy Rating
Baird Maintains IQVIA Holdings(IQV.US) With Hold Rating, Cuts Target Price to $213
No Data
No Data
